Literature DB >> 33670082

Metabolism of Innate Immune Cells in Cancer.

Ronan Talty1, Kelly Olino2.   

Abstract

Cancer cells possess specific metabolic requirements for their survival, proliferation, and progression. Within a shared microenvironment, immune cells depend on competing metabolic pathways for their development and effector function. As a result, local acidification, hypoxia, and nutrient depletion in the tumor microenvironment can alter the antitumor immune response and even promote resistance to immunotherapies such as immune checkpoint blockade and adoptive cell transfer. Although T cells are the primary effectors of the antitumor response, growing evidence demonstrates that innate immune cells are critical to successful tumor clearance. This review aims to summarize current research related to the innate immune system, metabolism, and cancer. We first discuss the specific metabolic requirements of innate immune cells for immune activation and suppression and conclude by highlighting ongoing clinical applications of these findings.

Entities:  

Keywords:  cancer; immunotherapy; innate immunity; metabolism

Year:  2021        PMID: 33670082      PMCID: PMC7927092          DOI: 10.3390/cancers13040904

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  154 in total

1.  Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice.

Authors:  R L Gamelli; H Liu; L K He; C A Hofmann
Journal:  J Leukoc Biol       Date:  1996-05       Impact factor: 4.962

2.  Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation.

Authors:  Connie M Krawczyk; Thomas Holowka; Jie Sun; Julianna Blagih; Eyal Amiel; Ralph J DeBerardinis; Justin R Cross; Euihye Jung; Craig B Thompson; Russell G Jones; Edward J Pearce
Journal:  Blood       Date:  2010-03-29       Impact factor: 22.113

3.  Metabolic requirements for neutrophil extracellular traps formation.

Authors:  Oscar Rodríguez-Espinosa; Oscar Rojas-Espinosa; María Maximina Bertha Moreno-Altamirano; Edgar Oliver López-Villegas; Francisco Javier Sánchez-García
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

4.  Essential Role of mTORC1 in Self-Renewal of Murine Alveolar Macrophages.

Authors:  Wenhai Deng; Jialong Yang; Xingguang Lin; Jinwook Shin; Jimin Gao; Xiao-Ping Zhong
Journal:  J Immunol       Date:  2016-11-23       Impact factor: 5.422

5.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α.

Authors:  G M Tannahill; A M Curtis; J Adamik; E M Palsson-McDermott; A F McGettrick; G Goel; C Frezza; N J Bernard; B Kelly; N H Foley; L Zheng; A Gardet; Z Tong; S S Jany; S C Corr; M Haneklaus; B E Caffrey; K Pierce; S Walmsley; F C Beasley; E Cummins; V Nizet; M Whyte; C T Taylor; H Lin; S L Masters; E Gottlieb; V P Kelly; C Clish; P E Auron; R J Xavier; L A J O'Neill
Journal:  Nature       Date:  2013-03-24       Impact factor: 49.962

6.  HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment.

Authors:  Cesar A Corzo; Thomas Condamine; Lily Lu; Matthew J Cotter; Je-In Youn; Pingyan Cheng; Hyun-Il Cho; Esteban Celis; David G Quiceno; Tapan Padhya; Thomas V McCaffrey; Judith C McCaffrey; Dmitry I Gabrilovich
Journal:  J Exp Med       Date:  2010-09-27       Impact factor: 14.307

Review 7.  Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.

Authors:  Arnoud J Templeton; Mairéad G McNamara; Boštjan Šeruga; Francisco E Vera-Badillo; Priya Aneja; Alberto Ocaña; Raya Leibowitz-Amit; Guru Sonpavde; Jennifer J Knox; Ben Tran; Ian F Tannock; Eitan Amir
Journal:  J Natl Cancer Inst       Date:  2014-05-29       Impact factor: 13.506

8.  Targeting Ornithine Decarboxylase by α-Difluoromethylornithine Inhibits Tumor Growth by Impairing Myeloid-Derived Suppressor Cells.

Authors:  Cong Ye; Zhe Geng; Donye Dominguez; Siqi Chen; Jie Fan; Lei Qin; Alan Long; Yi Zhang; Timothy M Kuzel; Bin Zhang
Journal:  J Immunol       Date:  2015-12-09       Impact factor: 5.422

9.  Fatty acid transport protein 2 reprograms neutrophils in cancer.

Authors:  Filippo Veglia; Vladimir A Tyurin; Maria Blasi; Alessandra De Leo; Andrew V Kossenkov; Laxminarasimha Donthireddy; Tsun Ki Jerrick To; Zach Schug; Subhasree Basu; Fang Wang; Emanuela Ricciotti; Concetta DiRusso; Maureen E Murphy; Robert H Vonderheide; Paul M Lieberman; Charles Mulligan; Brian Nam; Neil Hockstein; Gregory Masters; Michael Guarino; Cindy Lin; Yulia Nefedova; Paul Black; Valerian E Kagan; Dmitry I Gabrilovich
Journal:  Nature       Date:  2019-04-17       Impact factor: 49.962

10.  Improving the metabolic fidelity of cancer models with a physiological cell culture medium.

Authors:  Johan Vande Voorde; Tobias Ackermann; Nadja Pfetzer; David Sumpton; Gillian Mackay; Gabriela Kalna; Colin Nixon; Karen Blyth; Eyal Gottlieb; Saverio Tardito
Journal:  Sci Adv       Date:  2019-01-02       Impact factor: 14.136

View more
  10 in total

Review 1.  Informing the new developments and future of cancer immunotherapy : Future of cancer immunotherapy.

Authors:  Atul Kumar; Courtney A Swain; Lalita A Shevde
Journal:  Cancer Metastasis Rev       Date:  2021-05-18       Impact factor: 9.264

2.  Identification of an Innate Immune-Related Prognostic Signature in Early-Stage Lung Squamous Cell Carcinoma.

Authors:  Liang Li; Xue Yu; Guanqiang Ma; Zhiqi Ji; Shihao Bao; Xiaopeng He; Liang Song; Yang Yu; Mo Shi; Xiangyan Liu
Journal:  Int J Gen Med       Date:  2021-11-30

Review 3.  Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis.

Authors:  Qing Bi; Ji-Yue Wu; Xue-Meng Qiu; Jian-Dong Zhang; Ze-Jia Sun; Wei Wang
Journal:  J Immunol Res       Date:  2022-06-13       Impact factor: 4.493

4.  Necroptosis-Related LncRNAs Signature and Subtypes for Predicting Prognosis and Revealing the Immune Microenvironment in Breast Cancer.

Authors:  Yuhao Xu; Qinghui Zheng; Tao Zhou; Buyun Ye; Qiuran Xu; Xuli Meng
Journal:  Front Oncol       Date:  2022-05-24       Impact factor: 5.738

Review 5.  PGC1s and Beyond: Disentangling the Complex Regulation of Mitochondrial and Cellular Metabolism.

Authors:  Lara Coppi; Simona Ligorio; Nico Mitro; Donatella Caruso; Emma De Fabiani; Maurizio Crestani
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

Review 6.  New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs.

Authors:  Senthilnath Lakshmanachetty; Joselyn Cruz-Cruz; Eric Hoffmeyer; Allison P Cole; Siddhartha S Mitra
Journal:  Cells       Date:  2021-04-14       Impact factor: 6.600

7.  CD8+ T Cell-Based Molecular Classification With Heterogeneous Immunogenomic Landscapes and Clinical Significance of Clear Cell Renal Cell Carcinoma.

Authors:  Xiangkun Wu; Dongmei Jiang; Hongling Liu; Xiaofan Lu; Daojun Lv; Li Liang
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

Review 8.  New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment.

Authors:  Ji-Yong Sung; Jae-Ho Cheong
Journal:  Cells       Date:  2022-02-22       Impact factor: 6.600

9.  Research trends of cancer metabolism: analysis from a Chinese perspective.

Authors:  Yang Li; Jun Liu; Lichao Sun; Bin Zhang; Rong Shi
Journal:  Cancer Commun (Lond)       Date:  2022-04-26

Review 10.  The Role of Metabolic Plasticity of Tumor-Associated Macrophages in Shaping the Tumor Microenvironment Immunity.

Authors:  Md Nabiul Hasan; Okan Capuk; Shivani M Patel; Dandan Sun
Journal:  Cancers (Basel)       Date:  2022-07-08       Impact factor: 6.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.